These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36861451)

  • 21. Marine phospholipid nanoliposomes: A promising therapeutic approach for inflammatory bowel disease: Preparation, safety, and efficacy evaluation.
    Shabana S; Hamouda HI; Hamadou AH; Ahmed B; Chi Z; Liu C
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113702. PubMed ID: 38113752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical therapy of inflammatory bowel disease for the 21st century.
    Robinson M
    Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
    Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
    J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide in the treatment of inflammatory bowel disease.
    Silverman J; Otley A
    Expert Rev Clin Immunol; 2011 Jul; 7(4):419-28. PubMed ID: 21790284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
    Sarkate A; Dhaneshwar SS
    World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model.
    Qelliny MR; Aly UF; Elgarhy OH; Khaled KA
    AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.
    Bonovas S; Nikolopoulos GK; Lytras T; Fiorino G; Peyrin-Biroulet L; Danese S
    Br J Clin Pharmacol; 2018 Feb; 84(2):239-251. PubMed ID: 29057539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.
    Ma X; Gong H; Liu Y; Liu Y; Ogino K; Xing R; Yan X
    J Colloid Interface Sci; 2022 Nov; 626():156-166. PubMed ID: 35780549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
    Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
    Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety.
    Shi L; Wu X; Li T; Wu Y; Song L; Zhang W; Yin L; Wu Y; Han W; Yang Y
    Nanoscale Adv; 2022 Feb; 4(3):952-966. PubMed ID: 36131817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effect of liposomes loaded with chlorogenic acid in treatment of 2,4,6-trinitrobenzenesulfonic acid-induced murine colitis.
    Krajewska JB; Pietruszka P; Tomczyk D; Chen C; Owczarek A; Karolewicz B; Czapor-Irzabek H; Gorniak A; Fichna J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral locally active steroids in inflammatory bowel disease.
    Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
    J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment.
    Salmaso S; Mastrotto F; Roverso M; Gandin V; De Martin S; Gabbia D; De Franco M; Vaccarin C; Verona M; Chilin A; Caliceti P; Bogialli S; Marzaro G
    J Control Release; 2021 Dec; 340():318-330. PubMed ID: 34748872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.
    Kim JM; Kim DH; Park HJ; Ma HW; Park IS; Son M; Ro SY; Hong S; Han HK; Lim SJ; Kim SW; Cheon JH
    J Nanobiotechnology; 2020 Sep; 18(1):133. PubMed ID: 32933548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis.
    Ferri D; Costero AM; Gaviña P; Parra M; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
    Int J Pharm; 2019 Apr; 561():93-101. PubMed ID: 30817986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice.
    Ocón B; Aranda CJ; Gámez-Belmonte R; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F
    Biochem Pharmacol; 2016 Sep; 116():73-88. PubMed ID: 27431777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases.
    Sun Q; Luan L; Arif M; Li J; Dong QJ; Gao Y; Chi Z; Liu CG
    Carbohydr Polym; 2018 Jun; 189():352-359. PubMed ID: 29580419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.